Focusing on the research and development of pharmaceuticals for immunity adjustment, anti-inflammatory, analgesic, antibiotics, and anticancer, Tianji has one GMP workshop for peptide APIs production, and three GMP workshops for injections and freeze-dried powder injections.
So far, the platform for new drug development, the platform for peptides custom synthesis and manufacturing and the platform for protected amino acids synthesis have been established. Meanwhile, cooperating with several universities, the R&D center for finished dosages is one of the key centers in Suzhou.
more >
Year of Establishment:
-2001
Total Assets(USD):
15,000,000 To 19,999,999
Total Number of Staff:
250 to 299
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Contract Manufacturing,Buyers Specifications Accepted,Small Orders Accepted,Quality Service
Other Competitive Advantages:
Excellent experience on the peptides R&D and production.
Patents and Copyrights:
Business Type:
Manufacturer,Service Provider
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Excellent experience on the peptides R&D and production.
Patents and Copyrights: